T. Rowe Price Associates’s Loxo Oncology, Inc LOXO Stock Holding History

T. Rowe Price Associates’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,116,328	Closed	-$296M	–	2591
2018 Q4	$296M	Sell	2,116,328 -106,509	-5%	-$16.2M	0.05%	329
2018 Q3	$380M	Buy	2,222,837 +29,312	+1%	+$4.93M	0.06%	333
2018 Q2	$381M	Buy	2,193,525 +224,442	+11%	+$33.7M	0.06%	318
2018 Q1	$227M	Buy	1,969,083 +373,946	+23%	+$39.8M	0.04%	430
2017 Q4	$134M	Buy	1,595,137 +1,026,101	+180%	+$85.5M	0.02%	553
2017 Q3	$52.4M	Buy	569,036 +188,600	+50%	+$14.7M	0.01%	829
2017 Q2	$30.5M	Buy	380,436 +374,089	+5,894%	+$20.7M	0.01%	1014
2017 Q1	$267K	Buy	6,347 +10	+0.2%	+$412	﹤0.01%	2301
2016 Q4	$204K	Sell	6,337 -26,826	-81%	-$688K	﹤0.01%	2382
2016 Q3	$868K	Buy	+33,163	New	+$868K	﹤0.01%	1790

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

T. Rowe Price Associates's LOXO Position: Q1 2019 in Review

T. Rowe Price Associates sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 2,116,328 shares — an estimated $296M sold.

T. Rowe Price Associates first reported a position in LOXO in Q3 2016 and held it in 10 quarters. The position peaked at $381M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

T. Rowe Price Associates reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
T. Rowe Price Associates sold 2,116,328 Loxo Oncology, Inc shares in Q1 2019, an estimated $296M.
T. Rowe Price Associates first reported a position in Loxo Oncology, Inc in Q3 2016 and held it in 10 quarters.
T. Rowe Price Associates's Loxo Oncology, Inc position peaked at $381M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.